Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis
Clinical trial NCT03970733 · COMPLETED
Trial details
- NCT number
- NCT03970733
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2020-04-07
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.